Zoekresultaten - Torben Mourits‐Andersen
- Toon 1 - 6 resultaten van 6
-
1
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vinc... door Tina Green, Ken H. Young, Carlo Visco, Zijun Y. Xu‐Monette, Attilio Orazi, Ronald S. Go, Ole Nielsen, Ole Gadeberg, Torben Mourits‐Andersen, Mikael Frederiksen, Lars Møller Pedersen, Michael Møller
Gepubliceerd in 2012Artigo -
2
A phase <scp>III</scp> randomized trial comparing glucocorticoid monotherapy <i>versus</i> glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia door Henrik Birgens, Henrik Frederiksen, Hans Carl Hasselbalch, Inge Helleberg Rasmussen, Ove Juul Nielsen, Lars Kjeldsen, Herdis Larsen, Torben Mourits‐Andersen, Torben Plesner, Dorthe Rønnov‐Jessen, Hanne Vestergaard, Tobias Wirenfeldt Klausen, Claudia Schöllkopf
Gepubliceerd in 2013Artigo -
3
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia door Sif Gudbrandsdottir, Henrik Birgens, Henrik Frederiksen, Bjarne Anker Jensen, Morten Krogh Jensen, Lars Kjeldsen, Tobias Wirenfeldt Klausen, Herdis Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Ove Juul Nielsen, Torben Plesner, Stanislaw Pulczynski, Inge Helleberg Rasmussen, Dorthe Rønnov‐Jessen, Hans Carl Hasselbalch
Gepubliceerd in 2013Artigo -
4
Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis door Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov, Hans Carl Hasselbalch
Gepubliceerd in 2018Artigo -
5
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study door Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Dustin Andersen Patel, Lise Mette Rahbek Gjerdrum, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Christina Ellervik, Niels Pallisgaard, Mads Thomassen, Lasse Kjær, Vibe Skov, Hans Carl Hasselbalch
Gepubliceerd in 2019Artigo -
6
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses door Trine Alma Knudsen, Vibe Skov, Kristen E. Stevenson, Lillian Werner, William S. Duke, Charles Laurore, Christopher J. Gibson, Anwesha Nag, Aaron R. Thorner, Bruce M. Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Malthe Overgaard, Mikael Frederiksen, Thomas Kielsgaard Kristensen, Torben A. Kruse, Mads Thomassen, Torben Mourits‐Andersen, Marianne Tang Severinsen, Jesper Stentoft, Joern Starklint, Donna Neuberg, Lasse Kjær, Thomas Stauffer Larsen, Hans Carl Hasselbalch, R. Coleman Lindsley, Ann Mullally
Gepubliceerd in 2021Artigo
Zoekinstrumenten:
Gerelateerde Onderwerpen
Internal medicine
Medicine
Immunology
Oncology
Gastroenterology
Lymphoma
Rituximab
Biology
Bone marrow
Gene
Interferon
Myelofibrosis
Polycythemia vera
Prednisone
Ruxolitinib
Allele
Allele frequency
Alpha interferon
Antibody
B cell
BCL6
Biochemistry
CHOP
Chemotherapy
Chromosome
Combination therapy
Confidence interval
Cyclophosphamide
Dexamethasone
Diffuse large B-cell lymphoma